Showing 1401-1410 of 1969 results for "".
- Study: Rohrer Aesthetics Positions PIX:E as Breakthrough in Preventative Aesthetic Medicinehttps://modernaesthetics.com/news/study-rohrer-aesthetics-positions-pixe-as-breakthrough-in-preventative-aesthetic-medicine/2475544/Rohrer Aesthetics has released new clinical findings on its latest treatment platform, PIX:E, in a study recently featured by NewBeauty. The results suggest that PIX:E may offer a new paradigm in aesthetic care—shifting the focus from reactive treatment to preventative skin health. <
- Legal Firm Investigates Potential Securities Class Action Against GLP-1 Companyhttps://modernaesthetics.com/news/legal-firm-investigates-potential-securities-class-action-against-glp-1-company/2475480/Berger Montague, a securities litigation firm, is investigating potential claims on behalf of investors who purchased or acquired securities of Hims & Hers Health, Inc.The investigation follow
- Epicutis Introduces Skin Barrier Support Mist with Microbiome Focushttps://modernaesthetics.com/news/epicutis-introduces-skin-barrier-support-mist-with-microbiome-focus/2475454/Epicutis has announced the release of Hydrobiome Mist, a skin care product formulated to support skin barrier function and microbiome balance. The mist is intended to hydrate, protect agai
- SkinSpirit Shows Pride Month Support with $10,000 Donation to The Trevor Projecthttps://modernaesthetics.com/news/skinspirit-shows-pride-month-support-with-10000-donation-to-the-trevor-project/2475383/June kicked off Pride month in the United States and national medspa chain SkinSpirit is showing support through its philanthropic arm, SS Gives. SkinSpirit is donating $10,000 to The Trevor Project. “At SkinSpirit, one of our core values is leading with love,” Lynn Heublein, the co- foun
- GALDA Co-Director Explains Organization's Work and Impacthttps://modernaesthetics.com/news/galda-co-director-explains-organizations-work-and-impact/2475382/The Gay and Lesbian Dermatology Association (GALDA) is an organization of dermatologists and health-care professionals dedicated to unity and networking of the gay community at dermatology meetings. For Pride Month, we spoke with GALDA co-director William L Waller III, MD, FAAD, to learn more abo
- AB Chopra Epigenetics Launches With Plan to Revolutionize Longevityhttps://modernaesthetics.com/news/ab-chopra-epigenetics-launches-with-plan-to-revolutionize-longevity/2475380/Charles Rosier, co-founder of the Augustinus Bader skincare and biotech company, and Deepak Chopra, MD, announced the launch of AB Chopra Epigenetics, a revolutionary longevity platform that merges advanced artificial intelligence, epigenetic science, and consciousness-based healing to redefine t
- Dr. Sebastian Cotofana Shares Unpublished Research Targeting Glabellar Lines with Neurotoxins at SCALEhttps://modernaesthetics.com/news/dr-sebastian-cotofana-shares-unpublished-research-targeting-glabellar-lines-with-neurotoxins-at-scale/2475377/The 20th anniversary of Music City Symposium for Cosmetic Advances and Laser Education (SCALE) was held from May 14 to 18 at the Grand Hyatt in Nashville, Tennessee. The agenda included an update on neurotoxin related to facial anatomy for improved aesthetic outcomes from Seb
- Cartessa Aesthetics Brings Aesthetic Devices to Canadahttps://modernaesthetics.com/news/cartessa-aesthetics-brings-aesthetic-devices-to-canada/2475372/Cartessa Aesthetics is expanding its Canadian portfolio with the launch of four new technologies, HELIX, TORO, EVERESSE, and ULTRAFORMER MPT, according to a press release from the manufacturer. The new devices are expected to give Canadian providers access to some of the most ad
- FDA Panel Urges Removal of Talc from Consumer Products Due to Cancer Linkhttps://modernaesthetics.com/news/fda-panel-urges-removal-of-talc-from-consumer-products-due-to-cancer-link/2475371/A U.S. Food and Drug Administration (FDA) advisory panel has reinforced longstanding concerns over the carcinogenic potential of talc, urging the agency to restrict its use in foods, drugs, and cosmetics. Citing more
- First Patient Dosed with GPX4 Modulator Targeting Pathologic Senescent Cellshttps://modernaesthetics.com/news/first-patient-dosed-with-gpx4-modulator-targeting-pathologic-senescent-cells/2475369/The first patient has been dosed with the lead drug candidate RLS-1496 in a single-center, ascending-dose, randomized, double-blind, vehicle-controlled trial, Rubedo Life Sciences, Inc., announced in a press release. The study marks the first time a glutathio